MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2169/internalmedicine.0072-22

Медицинская библиотека · Internal medicine (Tokyo, Japan) · 2022

Lambert-Eaton Myasthenic Syndrome Recurrence Induced by Pembrolizumab in a Patient with Non-small-cell Lung Cancer.

Takigawa Yuki, Watanabe Hiromi, Omote Yoshio, Kurihara Sunao, Inoue Tomoyoshi, Fujiwara Miho, Mitsumune Sho, Onishi Kiriko, Kudo Kenichiro, Sato Akiko, Sato Ken, Fujiwara Keiichi, Shibayama Takuo

Клинический случайСтатьяПеревод в очереди

Аннотация

A 73-year-old woman in complete remission from localized small-cell lung cancer associated with Lambert-Eaton myasthenic syndrome (LEMS) 22 years earlier was referred to our hospital and diagnosed with non-small-cell lung cancer. After three courses of pembrolizumab, an immune checkpoint inhibitor, the patient complained of muscle weakness, fatigue, ptosis, and dysarthria. The anti-voltage-gated calcium channel antibody level was elevated, and waxing was observed on a high-frequency repetitive stimulation test using an electromyogram. We diagnosed her with recurrence of LEMS as an immune-related adverse event (irAE) induced by pembrolizumab. After intravenous immunoglobulin therapy, the patient's symptoms improved, and she was discharged.

Для цитирования: Takigawa Yuki, Watanabe Hiromi, Omote Yoshio, Kurihara Sunao, Inoue Tomoyoshi, Fujiwara Miho, Mitsumune Sho, Onishi Kiriko, Kudo Kenichiro, Sato Akiko, Sato Ken, Fujiwara Keiichi, Shibayama Takuo. Lambert-Eaton Myasthenic Syndrome Recurrence Induced by Pembrolizumab in a Patient with Non-small-cell Lung Cancer.. Internal medicine (Tokyo, Japan). 2022. DOI: 10.2169/internalmedicine.0072-22.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.